Регистрация
Расширенный поиск
RU EN
Главная
Последний номер
Архив номеров
Подписка
Контакты
Российское диализное общество

Просмотр статьи

<< Вернуться к списку статей журнала

Том 19 №3 2017 год - Нефрология и диализ

Современные представления о контраст-индуцированном остром почечном повреждении. Взгляд интервенционного радиолога


Хильчук А.А. Власенко С.В. Щербак С.Г. Сарана А.М. Бабунашвили А.М.

DOI: 10.28996/1680-4422-2017-3-407-417

Аннотация: Клинически значимое контраст-индуцированное повреждение (КИ-ОПП) является тяжелым осложнением рентген-эндоваскулярных процедур и связана с высокими показателями заболеваемости, смертности и значимыми социо-экономическими потерями. Повреждение почек после выполнения коронароангиографии или чрескожного коронарного вмешательства может развиться в 1-2% случаев общей популяции и у почти 50% пациентов с высоким риском развития КИ-ОПП. Основным и частым фактором, предрасполагающим к развитию контраст-индуцированного острого почечного повреждения, является уже имеющееся снижение почечной функции. Раннее выявление пациентов высокого риска развития КИ-ОПП со сниженной почечной функцией крайне важно для своевременного начала профилактических мер и последующего снижения вероятности повреждения почечной паренхимы с дальнейшим ухудшением почечной функции. Быстрая или почти мгновенная реакция некоторых биологических маркеров на субклиническое острое почечное повреждение помогает в диагностике нефропатии и на сегодняшний день является перспективным направлением исследования. Несмотря на небольшое количество имеющихся различий в рекомендациях, существует несколько строгих позиций в профилактике и лечении контраст-индуцированной нефропатии. Внутривенная нагрузка 0,9% раствором NaCl является единственной доказанной эффективной мерой профилактики КИ-ОПП, в то время как иная фармакологическая поддержка требует дальнейшего изучения и проведения большего количества проспективных исследований. Данная статья посвящена обзору современной литературы, посвященной причинам, профилактике и лечению КИ-ОПП с позиции доказательной медицины.

Для цитирования: Хильчук А.А., Власенко С.В., Щербак С.Г., Сарана А.М., Бабунашвили А.М. Современные представления о контраст-индуцированном остром почечном повреждении. Взгляд интервенционного радиолога. Нефрология и диализ. 2017. 19(3):407-417. doi: 10.28996/1680-4422-2017-3-407-417

Весь текст



Ключевые слова: нефропатия, повреждение почек, контрастные вещества, биомаркеры почечного повреждения, nephropathy, renal damage, contrast media, renal damage biomarkers

Список литературы:
  1. Almeida Mendes C. de и др. Carbon Dioxide as Contrast Medium to Guide Endovascular Aortic Aneurysm Repair. Annals of Vascular Surgery. 2017. 39. C. 67-73.
  2. Andreucci M. и др. Acute Kidney Injury by Radiographic Contrast Media : Pathogenesis and Prevention 2014.
  3. Ashalatha V.L. и др. Biomarker response to contrast administration in diabetic and nondiabetic patients following coronary angiography. Indian journal of nephrology. 2017. № 1 (27). C. 20-27.
  4. Aspelin P. и др. Nephrotoxic Effects in High-Risk Patients Undergoing Angiography. New England Journal of Medicine. 2009. № 6 (348). C. 2301-2303.
  5. Bachorzewska-Gajewska H. и др. Could Neutrophil-Gelatinase-Associated Lipocalin and Cystatin C Predict the Development of Contrast-Induced Nephropathy after Percutaneous Coronary Interventions in Patients with Stable Angina and Normal Serum Creatinine Values? Kidney and Blood Pressure Research. 2007. № 6 (30). C. 408-415.
  6. Bagshaw S.M., Culleton B.F. Contrast-induced nephropathy: Epidemiology and prevention. Minerva Cardioangiologica. 2006. Т. 54. № 1. 109-129 с.
  7. Bartels E.D. и др. Acute anuria following intravenous pyelography in a patient with myelomatosis. Acta medica Scandinavica. 1954. № 4 (150). C. 297-302.
  8. Bartholomew B.A. и др. Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. American Journal of Cardiology. 2004. № 12 (93). C. 1515-1519.
  9. Bonventre J. V. Kidney Injury Molecule-1 (KIM-1): A specific and sensitive biomarker of kidney injury. Scandinavian Journal of Clinical and Laboratory Investigation. 2008. № sup241 (68). C. 78-83.
  10. Brady H.R., Singer G.G. Acute Renal Failure. Lancet (London, England). 1995. № 8989 (346). C. 1448-1460.
  11. Brar S.S. и др. Sodium Bicarbonate vs Sodium Chloride for the Prevention of Contrast Undergoing Coronary Angiography. JAMA : the journal of the American Medical Association. 2008. № 9 (300). C. 1038-1046.
  12. Brezis M R.S. Hypoxia of the Renal Medulla - Its Implications for Disease. N Engl J Med. 1995. № 10 (332). C. 647-655.
  13. Briguori C. и др. RenalGuard system in high-risk patients for contrast-induced acute kidney injury. American Heart Journal. 2016. (173). C. 67-76.
  14. Bryant B.J., Im K., Broome D.R. Evaluation of the incidence of nephrogenic systemic fibrosis in patients with moderate renal insufficiency administered gadobenate dimeglumine for MRI. Clinical Radiology. 2009. № 7 (64). C. 706-713.
  15. Busch S.V.E. и др. Prevention of contrast-induced nephropathy in STEMI patients undergoing primary percutaneous coronary intervention: A systematic review. Journal of Interventional Cardiology. 2013. № 1 (26). C. 97-105.
  16. Caixeta A., Nikolsky E., Mehran R. Prevention and treatment of contrast-associated nephropathy in interventional cardiology. Current cardiology reports. 2009. № 5 (11). C. 377-83.
  17. Caridi J.G. Vascular Imaging with Carbon Dioxide: Confidence in a Safe, Efficacious, User-Friendly System. Seminars in interventional radiology. 2015. № 4 (32). C. 339-42.
  18. Chang C.-F., Lin C.-C. Current concepts of contrast-induced nephropathy: A brief review. Journal of the Chinese Medical Association. 2013. № 12 (76). C. 673-681.
  19. Choi M.-J. и др. The prevention of contrast-induced nephropathy by simultaneous hemofiltration during coronary angiographic procedures: A comparison with periprocedural hemofiltration. International Journal of Cardiology. 2014. № 3 (176). C. 941-945.
  20. Cigarroa R.G. и др. Dosing of contrast material to prevent contrast nephropathy in patients with renal disease. The American journal of medicine. 1989. № 6 Pt 1 (86). C. 649-52.
  21. Cooper M.W., Reed P.J. Comparison of ionic and non-ionic contrast agents in cardiac catheterization: the effects of ventriculography and coronary arteriography on hemodynamics, electrocardiography, and serum creatinine. Catheterization and cardiovascular diagnosis. 1991. № 4 (22). C. 267-77.
  22. Cubero-Gómez J.M. и др. Severe thrombocytopenia induced by iodinated contrast after coronary angiography: The use of gadolinium contrast and intravascular ultrasound as an alternative to guide percutaneous coronary intervention. Revista Portuguesa de Cardiologia. 2017. № 1 (36). C. 61.e1-61.e4.
  23. Dong Y. и др. How Strong Is the Evidence for Sodium Bicarbonate to Prevent Contrast-Induced Acute Kidney Injury After Coronary Angiography and Percutaneous Coronary Intervention?. Medicine. 2016. № 7 (95). C. e2715.
  24. Duan S.-B. и др. Urinary KIM-1, IL-18 and Cys-c as early predictive biomarkers in gadolinium-based contrast-induced nephropathy in the elderly patients. Clinical Nephrology. 2013. № 11 (80). C. 349-354.
  25. El-Ashmawy N.E. и др. Kidney injury molecule-1 (Kim-1): an early biomarker for nephropathy in type II diabetic patients. International Journal of Diabetes in Developing Countries. 2015. (35). C. 431-438.
  26. Filiopoulos V. и др. Plasma neutrophil gelatinase-associated lipocalin (NGAL) as an early predictive marker of contrast-induced nephropathy in hospitalized patients undergoing computed tomography. Clinical Kidney Journal. 2013. № 6 (6). C. 578-583.
  27. Filiopoulos V., Biblaki D., Vlassopoulos D. Neutrophil gelatinase-associated lipocalin (NGAL): a promising biomarker of contrast-induced nephropathy after computed tomography. Renal Failure. 2014. № 6 (36). C. 979-986.
  28. Finn W.F. The clinical and renal consequences of contrast-induced nephropathy. Nephrology Dialysis Transplantation. 2006. № Supplement 1 (21). C. i2-i10.
  29. Gernot Schilcher, Werner Ribitsch, Ronald Otto, et al. Early detection and intervention using neutrophil gelatinase-associated lipocalin (NGAL) may improve renal outcome of acute contrast media induced nephropathy: A randomized controlled trial in patients undergoing intra-arterial angiography. BMC Nephrol. 2011.
  30. Guan X. и др. Contrast Media-Induced Renal Inflammation Is Mediated Through HMGB1 and Its Receptors in Human Tubular Cells. DNA and Cell Biology. 2017. № 1 (36). C. 67-76.
  31. Han W.K. и др. Kidney Injury Molecule-1 (KIM-1): A novel biomarker for human renal proximal tubule injury. Kidney International. 2002. № 1 (62). C. 237-244.
  32. Haschek E L.O. A contribution to the practical use of photography according to Roentgen. Wien Chir Wochenschr. 1896. № 9. C. 63.
  33. He A. и др. Nephrogenic systemic fibrosis: fibrotic plaques and contracture following exposure to gadolinium-based contrast media. BMJ case reports. 2016. C. bcr2016214927.
  34. Hörl W.H. Contrast induced nephropathy. Wiener klinische Wochenschrift. 2009. № 1-2 (121). C. 15-32.
  35. Hou S.H. и др. Hospital-acquired renal insufficiency: a prospective study. The American journal of medicine. 1983. № 2 (74). C. 243-8.
  36. Jo S.-H. и др. Renal toxicity evaluation and comparison between visipaque (iodixanol) and hexabrix (ioxaglate) in patients with renal insufficiency undergoing coronary angiography: the RECOVER study: a randomized controlled trial. Journal of the American College of Cardiology. 2006. № 5 (48). C. 924-30.
  37. Kalyesubula R., Bagasha P., Perazella M.A. ACE-I / ARB Therapy prior to Contrast Exposure : What Should the Clinician Do? 2014.
  38. Kellum J.A. и др. Development of a clinical research agenda for acute kidney injury using an international, interdisciplinary, three-step modified delphi process. Clinical Journal of the American Society of Nephrology. 2008. № 3 (3). C. 887-894.
  39. Khwaja A. KDIGO clinical practice guidelines for acute kidney injury. Nephron - Clinical Practice. 2012. № 4 (120). C. 179-184.
  40. Killmann S.A., Gjorup S., Thaysen J.H. Fatal acute renal failure following intravenous pyelography in a patient with multiple myeloma. Acta medica Scandinavica. 1957. № 1 (158). C. 43-6.
  41. Lichosik M. и др. Interleukin 18 and neutrophil-gelatinase associated lipocalin in assessment of the risk of contrast-induced nephropathy in children. Central European Journal of Immunology. 2015. № 4 (40). C. 447-453.
  42. Loughlin K.R., Hawtrey C.E. Moses Swick, the father of intravenous urography. Urology. 2003. № 2 (62). C. 385-9.
  43. Maioli M. и др. Sodium Bicarbonate Versus Saline for the Prevention of Contrast-Induced Nephropathy in Patients With Renal Dysfunction Undergoing Coronary Angiography or Intervention. Journal of the American College of Cardiology. 2008. № 8 (52). C. 599-604.
  44. Maioli M. и др. Preprocedural score for risk of contrast-induced nephropathy in elective coronary angiography and intervention. Journal of cardiovascular medicine (Hagerstown, Md.). 2010. № 6 (11). C. 444-9.
  45. Malyszko J. и др. Urinary and Serum Biomarkers after Cardiac Catheterization in Diabetic Patients with Stable Angina and without Severe Chronic Kidney Disease. Renal Failure. 2009. № 10 (31). C. 910-919.
  46. Mawad H. и др. Changes in urinary and serum levels of novel biomarkers after administration of gadolinium-based contrast agents. Biomarker Insights. 2016. (11). C. 91-94.
  47. McCullough P.A. и др. Risk Prediction of Contrast-Induced Nephropathy. The American Journal of Cardiology. 2006. № 6 (98). C. 27-36.
  48. McCullough P.A. Contrast-Induced Acute Kidney Injury. Journal of the American College of Cardiology. 2008. № 15 (51). C. 1419-1428.
  49. McCullough P.A. и др. Contrast-Induced Acute Kidney Injury. Journal of the American College of Cardiology. 2016. № 13 (68). C. 1465-1473.
  50. McCullough P.A., Sandberg K.R. Epidemiology of contrast-induced nephropathy. Reviews in cardiovascular medicine. 2003. (4 Suppl 5). C. S3-9.
  51. Mehran R. и др. A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: Development and initial validation. Journal of the American College of Cardiology. 2004. № 7 (44). C. 1393-1399.
  52. Mehran R. и др. Ionic Low-Osmolar Versus Nonionic Iso-Osmolar Contrast Media to Obviate Worsening Nephropathy After Angioplasty in Chronic Renal Failure Patients. JACC: Cardiovascular Interventions. 2009. № 5 (2). C. 415-421.
  53. Mehran R., Nikolsky E. Contrast-induced nephropathy: definition, epidemiology, and patients at risk. Kidney international. Supplement. 2006. № 100 (69). C. S11-S15.
  54. Michaely H.J. и др. Gadobutrol in Renally Impaired Patients. Investigative Radiology. 2017. № 1 (52). C. 55-60.
  55. Morcos S.K., Thomsen H.S., Webb J.A. Contrast-media-induced nephrotoxicity: a consensus report. Contrast Media Safety Committee, European Society of Urogenital Radiology (ESUR). European radiology. 1999. № 8 (9). C. 1602-13.
  56. Nash K., Hafeez A., Hou S. Hospital-acquired renal insufficiency. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2002. № 5 (39). C. 930-6.
  57. Osborne E.D. и др. Landmark article Feb 10, 1923: Roentgenography of urinary tract during excretion of sodium iodid. By Earl D. Osborne, Charles G. Sutherland, Albert J. Scholl, Jr. and Leonard G. Rowntree. JAMA. 1983. № 20 (250). C. 2848-53.
  58. Ozawa Y. и др. Effects of Gadodiamide on cell proliferation and collagen production in cultured human dermal fibroblasts. Archives of Dermatological Research. 2016. № 10 (308). C. 695-701.
  59. Parfrey P. The clinical epidemiology of contrast-induced nephropathy. Cardiovasc Intervent Radiol. 2005. (28 Suppl 2). C. S3-11.
  60. Pianta T.J. и др. Monitoring Treatment of Acute Kidney Injury with Damage Biomarkers. Toxicology Letters. 2017.
  61. Rear R., Bell R.M., Hausenloy D.J. Education in Heart Contrast-induced nephropathy following angiography and cardiac interventions. Heart. 2016. C. 638-648.
  62. Renton M. и др. The use of carbon dioxide angiography for renal sympathetic denervation: a technical report. The British Journal of Radiology. 2016. № 1068 (89). C. 20160311.
  63. Rey J.R. и др. Prevention of contrast-induced nephropathy with haemofiltration in high-risk patients after percutaneous coronary intervention. Acute Cardiac Care. 2011. № 3 (13). C. 164-169.
  64. Ribichini F. и др. Early creatinine shifts predict contrast-induced nephropathy and persistent renal damage after angiography. American Journal of Medicine. 2010. № 8 (123). C. 755-763.
  65. Ribichini F. и др. Comparison of serum creatinine and cystatin C for early diagnosis of contrast-induced nephropathy after coronary angiography and interventions. Clinical Chemistry. 2012. № 2 (58). C. 458-464.
  66. Ribitsch W. и др. Neutrophil gelatinase-associated lipocalin (NGAL) fails as an early predictor of contrast induced nephropathy in chronic kidney disease (ANTI-CI-AKI study). Scientific reports. 2017. (7). C. 41300.
  67. Rittenhouse D.R. и др. Contrast media use in patients with chronic kidney disease undergoing coronary angiography: A systematic review and meta-analysis of randomized trials. New England Journal of Medicine. 2017. № 6 (228). C. 137-144.
  68. Rudnick M.R. и др. Contrast media-associated nephrotoxicity. Seminars in nephrology. 1997. № 1 (17). C. 15-26.
  69. Sarabu N., Rahman M. Nephrology Update: Acute Kidney Injury. FP essentials. 2016. (444). C. 11-7.
  70. Sendeski M.M. Pathophysiology of renal tissue damage by iodinated contrast media. Clinical and Experimental Pharmacology and Physiology. 2011. № 5 (38). C. 292-299.
  71. Sendeski M.M. и др. Iodinated contrast media cause endothelial damage leading to vasoconstriction of human and rat vasa recta. AJP: Renal Physiology. 2012. C. 1592-1598.
  72. Solomon R.J. и др. Contrast-induced nephropathy and long-term adverse events: Cause and effect?. Clinical Journal of the American Society of Nephrology. 2009. № 7 (4). C. 1162-1169.
  73. Soulez G. и др. Prospective Cohort Study of Nephrogenic Systemic Fibrosis in Patients With Stage 3-5 Chronic Kidney Disease Undergoing MRI With Injected Gadobenate Dimeglumine or Gadoteridol. American Journal of Roentgenology. 2015. № 3 (205). C. 469-478.
  74. Spini V. и др. Effects of two different treatments with continuous renal replacement therapy in patients with chronic renal dysfunction submitted to coronary invasive procedures. The Journal of invasive cardiology. 2013. № 2 (25). C. 80-4.
  75. Sudarsky D., Nikolsky E. Contrast-induced nephropathy in interventional cardiology. International Journal of Nephrology and Renovascular Disease. 2011. (4). C. 85-99.
  76. Tamai N. и др. Sodium bicarbonate for the prevention of contrast-induced nephropathy: the efficacy of high concentration solution. The Journal of invasive cardiology. 2012. № 9 (24). C. 439-42.
  77. Tepel M. и др. Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine. The New England journal of medicine. 2000. № 3 (343). C. 180-4.
  78. Timmeren M.M. van и др. Tubular kidney injury molecule-1 (KIM-1) in human renal disease Journal of Pathology. 2007. № 2 (212). C. 209-217.
  79. Tziakas D. и др. Development of an easily applicable risk score model for contrast-induced nephropathy prediction after percutaneous coronary intervention: A novel approach tailored to current practice. International Journal of Cardiology. 2013. № 1 (163). C. 46-55.
  80. Victor S.M. и др. Risk scoring system to predict contrast induced nephropathy following percutaneous coronary intervention. Indian Heart Journal. 2014. № 5 (66). C. 517-524.
  81. Waikar S.S., Bonventre J.V. Creatinine kinetics and the definition of acute kidney injury. Journal of the American Society of Nephrology : JASN. 2009. (20). C. 672-679.
  82. Wang N. и др. The effect of N-acetylcysteine on the incidence of contrast-induced kidney injury: A systematic review and trial sequential analysis. International Journal of Cardiology. 2016. (209). C. 319-327.
  83. Weisbord S.D. и др. Associations of Increases in Serum Creatinine with Mortality and Length of Hospital Stay after Coronary Angiography. Journal of American Society of Nephrology. 2006. (17). C. 2871-2877.
  84. Weisz G. и др. Safety and Performance of Targeted Renal Therapy: The Be-RITe! Registry. Journal of Endovascular Therapy. 2009. № 1 (16). C. 1-12.
  85. Wu Y.W. и др. Prevention and Management of Adverse Reactions Induced by Iodinated Contrast Media. Annals of the Academy of Medicine, Singapore. 2016. № 4 (45). C. 157-64.
  86. You W. и др. The value of urinary neutrophil gelatinase-associated lipocalin for early diagnosis of contrast-induced nephropathy]. Zhonghua xin xue guan bing za zhi. 2016. № 12 (44). C. 1024-1029.
  87. Zhao X. и др. Kidney Injury Molecule-1 Enhances Endocytosis of Albumin in Renal Proximal Tubular Cells. Journal of Cellular Physiology. 2016. № 4 (231). C. 896-907.

Другие статьи по теме


Навигация по статьям
<< Предыдущая
Следующая >>
Разделы журнала
Наиболее читаемые статьи

Земченков А.Ю.,  Как развивался EVOLVE. Обзор одного исследования  2716

Булгатов Д.А., Ильичева Е.А.,  Спорные вопросы хирургического лечения вторичного гиперпаратиреоза. Обзор литературы  2326

Земченков А.Ю., Герасимчук Р.П., Сабодаш А.Б. и соавт.,  Анемия у пациентов с ХБП 5: актуальные тренды в мире и картина в Санкт-Петербурге  2271

Журнал "Нефрология и диализ"
Главная
Последний номер
Архив номеров
Подписка
Контакты